Trial Profile
A Non-interventional Study of Postoperative Treatment With Goserelin Acetate (Zoladex) in Moderate to Severe Endometriosis Patient.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2014
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 12 Mar 2012 Actual patient number (426) added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Actual end date (February 2012) added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.